Revisiting the basic symptom concept: Toward translating risk symptoms for psychosis into neurobiological targets

Frontiers in Psychiatry

Volumn 7, Issue JAN, 2016, Pages

  Schultze Lutter, Frauke ^a   Debbané, Martin ^b,c   Theodoridou, Anastasia ^d   Wood, Stephen J ^e   Raballo, Andrea ^f   Michel, Chantal ^a   Schmidt, Stefanie J ^a   Kindler, Jochen ^a   Ruhrmann, Stephan ^g   Uhlhaas, Peter J ^h  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF OSLO   (Norway)

^g UNIVERSITY OF COLOGNE   (Germany)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Aetiopathology; Basic symptoms; Clinical high risk; Neurobiology; Psychosis

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; GLUTAMIC ACID; SEROTONIN;

ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COPING BEHAVIOR; DELUSION; DISEASE ASSOCIATION; DOPAMINERGIC TRANSMISSION; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC TRANSMISSION; HALLUCINATION; HUMAN; IN VIVO STUDY; MEDICAL RESEARCH; NERVE CELL NETWORK; NEUROCHEMISTRY; NEUROPATHOLOGY; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RISK FACTOR; SEROTONINERGIC TRANSMISSION; STRESS;

EID: 84964680189     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2016.00009     Document Type: Article

References (74)

1. Huber G, Gross G. The concept of basic symptoms in schizophrenic and schizoaffective psychoses. Recent Prog Med (1989) 80:646-52.
2. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull (2009) 35(1):5-8. doi: 10.1093/schbul/sbn139
3. Koehler K, Sauer H. Huber's basic symptoms: another approach to negative psychopathology in schizophrenia. Compr Psychiatry (1984) 25(2):174-82. doi:10.1016/0010-440X(84)90006-3
4. Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG, Klosterkötter J. Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des (2012) 18(4):351-7. doi:10.2174/138161212799316064
5. Parnas J, Handest P, Jansson L, Sæbye D. Anomalous subjective experience among first-admitted schizophrenia spectrum patients: empirical investigation. Psychopathology (2005) 38:259-67. doi:10.1159/000088442
6. Parnas J, Møller P, Kircher T, Thalbitzer J, Jansson L, Handest P, et al. Examination of anomalous self-experience. Psychopathology (2005) 38(5):236-58. doi:10.1016/S0013-7006(12)70090-8
7. Raballo A, Parnas J. The silent side of the spectrum: schizotypy and the schizotaxic self. Schizophr Bull (2011) 37(5):1017-26. doi:10.1093/schbul/sbq008
8. Huber G. Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr Neurol Psychiatr (1966) 34:409-26.
9. Huber G. Indizien für die Somatosehypothese bei den Schizophrenien. Fortschr Neurol Psychiatr (1976) 44:77-94.
10. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry (2001) 58(2):158-64. doi:10.1001/archpsyc.58.2.158
11. Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RK, et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry (2015) 30(3):405-16. doi:10.1016/j.eurpsy.2015.01.010
12. Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J. Schizophrenia Proneness Instrument, Adult version (SPI-A). Rom: Giovanni Fioriti Editore s.r.l. (2007). 97 p.
13. de Paula AL, Hallak JE, Maia-de-Oliveira JP, Bressan RA, Machado-de-Sousa JP. Cognition in at-risk mental states for psychosis. Neurosci Biobehav Rev (2015) 57:199-208. doi:10.1016/j.neubiorev.2015.09.006
14. Frommann I, Pukrop R, Brinkmeyer J, Bechdolf A, Ruhrmann S, Berning J, et al. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early-and additional memory dysfunction in the late-prodromal state. Schizophr Bull (2011) 37(4):861-73. doi:10.1093/schbul/sbp155
15. Pukrop R, Schultze-Lutter F, Ruhrmann S, Brockhaus-Dumke A, Tendolkar I, Bechdolf A, et al. Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first-and multiple-episode schizophrenia. J Clin Exp Neuropsychol (2006) 28(8):1388-407. doi:10.1080/13803390500434425
16. Simon AE, Cattapan-Ludewig K, Zmilacher S, Arbach D, Gruber K, Dvorsky DN, et al. Cognitive functioning in the schizophrenia prodrome. Schizophr Bull (2007) 33(3):761-71. doi:10.1093/schbul/sbm018
17. Schultze-Lutter F, Ruhrmann S, Picker H, von Reventlow HG, Daumann B, Brockhaus-Dumke A, et al. Relationship between subjective and objective cognitive function in the early and late prodrome. Br J Psychiatry Suppl (2007) 51:s43-51. doi:10.1192/bjp.191.51.s43
18. Simon AE, Grädel M, Cattapan-Ludewig K, Gruber K, Ballinari P, Roth B, et al. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome. Schizophr Res (2012) 142(1-3):108-15. doi:10.1016/j.schres.2012.09.004
19. Koutsouleris N, Davatzikos C, Bottlender R, Patschurek-Kliche K, Scheuerecker J, Decker P, et al. Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull (2012) 38(6):1200-15. doi:10.1093/schbul/sbr037
20. Haug E, Øie M, Melle I, Andreassen OA, Raballo A, Bratlien U, et al. The association between self-disorders and neurocognitive dysfunction in schizophrenia. Schizophr Res (2012) 135(1-3):79-83. doi:10.1016/j.schres.2011.11.015
21. Nordgaard J, Revsbech R, Henriksen MG. Self-disorders, neurocognition and rationality in schizophrenia: a preliminary study. Psychopathology (2015) 48(5):310-6. doi:10.1159/000435892
22. Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, et al. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Aust N Z J Psychiatry (2010) 44(3):230-6. doi:10.3109/00048670903487118
23. Morgan CJ, Duffin S, Hunt S, Monaghan L, Mason O, Curran HV. Neurocognitive function and schizophrenia-proneness in individuals dependent on ketamine, on high potency cannabis ('skunk') or on cocaine. Pharmacopsychiatry (2012) 45(7):269-74. doi:10.1055/s-0032-1306310
24. Koethe D, Giuffrida A, Schreiber D, Hellmich M, Schultze-Lutter F, Ruhrmann S, et al. Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis. Br J Psychiatry (2009) 194(4):371-2. doi:10.1192/bjp.bp.108.053843
25. Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, Gerth CW, et al. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One (2007) 2(8):e756. doi:10.1371/journal.pone.0000756
26. Wölwer W, Brinkmeyer J, Stroth S, Streit M, Bechdolf A, Ruhrmann S, et al. Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia. Schizophr Bull (2012) 38(5):1021-9. doi:10.1093/schbul/sbr013
27. Frommann I, Brinkmeyer J, Ruhrmann S, Hack E, Brockhaus-Dumke A, Bechdolf A, et al. Auditory P300 in individuals clinically at risk for psychosis. Int J Psychophysiol (2008) 70(3):192-205. doi:10.1016/j.ijpsycho.2008.07.003
28. Arnfred SM, Raballo A, Morup M, Parnas J. Self-disorder and brain processing of proprioception in schizophrenia spectrum patients: a re-analysis. Psychopathology (2015) 48(1):60-4. doi:10.1159/000366081
29. Sestito M, Raballo A, Umiltà MA, Leuci E, Tonna M, Fortunati R, et al. Mirroring the self: testing neurophysiological correlates of disturbed self-experience in schizophrenia spectrum. Psychopathology (2015) 48(3):184-91. doi:10.1159/000380884
30. Sestito M, Raballo A, Umiltà MA, Amore M, Maggini C, Gallese V. Anomalous echo: exploring abnormal experience correlates of emotional motor resonance in Schizophrenia Spectrum. Psychiatry Res (2015) 229(1-2):559-64. doi:10.1016/j.psychres.2015.05.038
31. van Tricht MJ, Ruhrmann S, Arns M, Müller R, Bodatsch M, Velthorst E, et al. Can quantitative EEG measures predict clinical outcome in subjects at clinical high risk for psychosis? A prospective multicenter study. Schizophr Res (2014) 153(1-3):42-7. doi:10.1016/j.schres.2014.01.019
32. Andreou C, Leicht G, Nolte G, Polomac N, Moritz S, Karow A, et al. Resting-state theta-band connectivity and verbal memory in schizophrenia and in the high-risk state. Schizophr Res (2015) 161(2-3):299-307. doi:10.1016/j.schres.2014.12.018
33. Ramyead A, Kometer M, Studerus E, Koranyi S, Ittig S, Gschwandtner U, et al. Aberrant current source-density and lagged phase synchronization of neural oscillations as markers for emerging psychosis. Schizophr Bull (2015) 41(4):919-29. doi:10.1093/schbul/sbu134
34. Hurlemann R, Jessen F, Wagner M, Frommann I, Ruhrmann S, Brockhaus A, et al. Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychol Med (2008) 38(6):843-51. doi:10.1017/S0033291708003279
35. Koutsouleris N, Schmitt GJ, Gaser C, Bottlender R, Scheuerecker J, McGuire P, et al. Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. Br J Psychiatry (2009) 195(3):218-26. doi:10.1192/bjp.bp.108.052068
36. Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, et al. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry (2009) 66(7):700-12. doi:10.1001/archgenpsychiatry.2009.62
37. Koutsouleris N, Davatzikos C, Borgwardt S, Gaser C, Bottlender R, Frodl T, et al. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull (2014) 40(5):1140-53. doi:10.1093/schbul/sbt142
38. Tepest R, Schwarzbach CJ, Krug B, Klosterkötter J, Ruhrmann S, Vogeley K. Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 263(1):15-24. doi:10.1007/s00406-012-0343-6
39. Ebisch SJ, Mantini D, NorthoffG, Salone A, De Berardis D, Ferri F, et al. Altered brain long-range functional interactions underlying the link between aberrant self-experience and self-other relationship in first-episode schizophrenia. Schizophr Bull (2014) 40(5):1072-82. doi:10.1093/schbul/sbt153
40. Ebisch SJ, Salone A, Ferri F, De Berardis D, Romani GL, Ferro FM, et al. Out of touch with reality? Social perception in first-episode schizophrenia. Soc Cogn Affect Neurosci (2013) 8(4):394-403. doi:10.1093/scan/nss012
41. Wotruba D, Michels L, Buechler R, Metzler S, Theodoridou A, Gerstenberg M, et al. Aberrant coupling within and across the default mode, task-positive, and salience network in subjects at risk for psychosis. Schizophr Bull (2014) 40(5):1095-104. doi:10.1093/schbul/sbt161
42. Wotruba D, Heekeren K, Michels L, Buechler R, Simon JJ, Theodoridou A, et al. Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis. Front Behav Neurosci (2014) 8:382. doi:10.3389/fnbeh.2014.00382
43. Ferri F, Costantini M, Salone A, Ebisch S, De Berardis D, Mazzola V, et al. Binding action and emotion in first-episode schizophrenia. Psychopathology (2014) 47(6):394-407. doi:10.1159/000366133
44. Steeds H, Carhart-Harris RL, Stone JM. Drug models of schizophrenia. Ther Adv Psychopharmacol (2015) 5(1):43-58. doi:10.1177/2045125314557797
45. Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL. Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp (2015) 36(8):3137-53. doi:10.1002/hbm.22833
46. Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry (2011) 168(12):1311-7. doi:10.1176/appi.ajp.2011.11010160
47. Egerton A, Chaddock CA, Winton-Brown TT, Bloomfield MA, Bhattacharyya S, Allen P, et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry (2013) 74(2):106-12. doi:10.1016/j.biopsych.2012.11.017
48. Allen P, Chaddock CA, Egerton A, Howes OD, Barker G, Bonoldi I, et al. Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation. Schizophr Bull (2015) 41(2):429-39. doi:10.1093/schbul/sbu115
49. de la Fuente-Sandoval C, León-Ortiz P, Favila R, Stephano S, Mamo D, Ramírez-Bermúdez J, et al. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis. Neuropsychopharmacology (2011) 36(9):1781-91. doi:10.1038/npp.2011.65
50. de la Fuente-Sandoval C, Reyes-Madrigal F, Mao X, León-Ortiz P, Rodríguez-Mayoral O, Solís-Vivanco R, et al. Cortico-striatal GABAergic and glutamatergic dysregulations in subjects at ultra-high risk for psychosis investigated with proton magnetic resonance spectroscopy. Int J Neuropsychopharmacol (2015). doi:10.1093/ijnp/pyv105
51. Kang JI, Park HJ, Kim SJ, Kim KR, Lee SY, Lee E, et al. Reduced binding potential of GABA-A/benzodiazepine receptors in individuals at ultra-high risk for psychosis: an [18F]-fluoroflumazenil positron emission tomography study. Schizophr Bull (2014) 40(3):548-57. doi:10.1093/schbul/sbt052
52. Huttunen J, Heinimaa M, Svirskis T, Nyman M, Kajander J, Forsback S, et al. Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol Psychiatry (2008) 63(1):114-7. doi:10.1016/j.biopsych.2007.04.017
53. Liu L, Ioannides AA. Emotion separation is completed early and it depends on visual field presentation. PLoS One (2010) 5(3):e9790. doi:10.1371/journal.pone.0009790
54. Nagai T, Tada M, Kirihara K, Araki T, Jinde S, Kasai K. Mismatch negativity as a "translatable" brain marker toward early intervention for psychosis: a review. Front Psychiatry (2013) 4:115. doi:10.3389/fpsyt.2013.00115
55. Uhlhaas PJ, Singer W. Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities. Biol Psychiatry (2015) 77(12):1001-9. doi:10.1016/j.biopsych.2014.11.019
56. Wang XJ. Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev (2010) 90(3):1195-268. doi:10.1152/physrev.00035.2008
57. Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull (2010) 83(3-4):108-21. doi:10.1016/j.brainresbull.2010.04.006
58. Lewis DA, Hashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci (2005) 6(4):312-24. doi:10.1038/nrn1648
59. Chung Y, Cannon TD. Brain imaging during the transition from psychosis prodrome to schizophrenia. J Nerv Ment Dis (2015) 203(5):336-41. doi:10.1097/NMD.0000000000000286
60. Fornito A, Yücel M, Patti J, Wood SJ, Pantelis C. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res (2009) 108(1-3):104-13. doi:10.1016/j.schres.2008.12.011
61. Schultz CC, Fusar-Poli P, Wagner G, Koch K, Schachtzabel C, Gruber O, et al. Multimodal functional and structural imaging investigations in psychosis research. Eur Arch Psychiatry Clin Neurosci (2012) 262(Suppl 2):S97-106. doi:10.1007/s00406-012-0360-5
62. Borgwardt SJ, Stoyanov DS. Emerging psychiatric neuroimaging findings: translating the research into clinical application. In: Stoyanov DS, editor. Towards New Philosophy and Mental Health, Perspectives from Neuroscience and Humanities. Newcastle upon Tyne: Cambridge Scholars Publishing (2015). p. 35-41.
63. Schultze-Lutter F, Steinmeyer EM, Ruhrmann S, Klosterkötter J. The dimensional structure of self-reported 'prodromal' disturbances in schizophrenia. Clin Neuropsychiatry (2008) 5(3):140-50.
64. Mishara A, Bonoldi I, Allen P, Rutigliano G, Perez J, Fusar-Poli P, et al. Neurobiological models of self-disorders in early schizophrenia. Schizophr Bull (2015). doi:10.1093/schbul/sbv123
65. Kreisler A, Godefroy O, Delmaire C, Debachy B, Leclercq M, Pruvo JP, et al. The anatomy of aphasia revisited. Neurology (2000) 54(5):1117-23. doi:10.1212/WNL.54.5.1117
66. Schultze-Lutter F, Michel C, Schimmelmann BG. Impact of age on the prevalence and clinical significance of risk-symptoms in 8-to 40-year-olds of the general population. Eur Arch Psychiatry Clin Neurosci (2015) 265(Suppl 1):S11.
67. Paus T, Keshavan M, Giedd JN. Why do many psychiatric disorders emerge during adolescence? Nat Rev Neurosci (2008) 9(12):947-57. doi:10.1038/nrn2513
68. Klosterkötter J, Gross G, Huber G, Wieneke A, Steinmeyer EM, Schultze-Lutter F. Evaluation of the 'Bonn Scale for the Assessment of Basic Symptoms-BSABS' as an instrument for the assessment of schizophrenia proneness: a review of recent findings. Neurol Psychiatry Brain Res (1997) 5:137-50.
69. Raballo A, Sæbye D, Parnas J. Looking at the schizophrenia spectrum through the prism of self-disorders: an empirical study. Schizophr Bull (2011) 37(2):344-51. doi:10.1093/schbul/sbp056
70. Maggini C, Raballo A. Subjective experience of schizotropic vulnerability in siblings of schizophrenics. Psychopathology (2004) 37(1):23-8. doi:10.1159/000077016
71. Maggini C, Raballo A. Subjective experience of personality dimensions in 1st degree relatives of schizophrenics. Acta Biomed (2003) 74(3):131-6.
72. Maggini C, Raballo A. Subjective experience of schizotypal dimensions in 1st degree relatives of schizophrenics. Neurol Psychiatry Brain Res (2004) 11:71-6.
73. Handest P, Parnas J. Clinical characteristics of first-admitted patients with ICD-10 schizotypal disorder. Br J Psychiatry Suppl (2005) 48:s49-54. doi:10.1192/bjp.187.48.s49
74. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature (2014) 511(7510):421-7. doi:10.1038/nature13595